unknown
Stage
1
Investors
About
Cartography Biosciences develops precise cancer immunotherapies by using single-cell genomics and proprietary computational platforms to identify specific and safe tumor targets across a broad range of cancers.
Explore Cartography Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.